Equity Overview
Price & Market Data
Price: $24.70
Daily Change: -$0.77 / 3.12%
Daily Range: $24.05 - $26.47
Market Cap: $1,084,112,640
Daily Volume: 26,695
Performance Metrics
1 Week: -2.10%
1 Month: -26.47%
3 Months: -6.83%
6 Months: -51.14%
1 Year: 335.6%
YTD: -17.86%
Company Details
Employees: 27
Sector: Health technology
Industry: Medical specialties
Country:
Details
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.